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Balloon dilation is widely accepted to be the treatment of
choice for recoarctation of the aorta after previous surgical
repair. There is a lower morbidity than with repeat surgery
and a high success rate (1). Native coarctation is also
successfully treated with balloon dilation, but is generally
avoided in the first 6 to 12 months of life owing to a high
incidence of recoarctation and femoral artery damage (2). In
older children and adults, it is widely used despite concerns
that dissection and rupture are more of a risk than in
recoarctation, where scarring and adhesions from previous
surgery may better support the aortic wall (3). However,
acute rupture has been reported after balloon dilation for
recoarctation (4). In the longer term, concerns exist about
aneurysm formation and recoarctation—though these also
occur after surgical repair for coarctation (5,6).
Balloon dilation relieves the aortic obstruction by tearing
the coarctation shelf with variable extension into the media.
Tears into the adjacent “normal” aortic wall may reflect an
inherent weakness in the aorta in patients with coarctation
(7). If extensive, these tears can lead to acute rupture or
dissection and chronic aneurysm formation. The rationale
for stent implantation is that overdilation of the coarctation
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segment is unnecessary, thus avoiding major transmural
tears while at the same time the stent struts will splint any
smaller tears against the aortic wall, preventing progressive
dissection and aneurysm formation. Additionally, the acute
elastic recoil of the coarctation segment, which contributes
to a suboptimal initial result and late recoarctation, is
prevented by stent implantation, leading to a greater relief of
obstruction than with balloon dilation alone.
Endovascular stent implantation is now increasingly used
in place of balloon dilation for both native coarctation and
recoarctation in older children and adults (8–14). There is a
much smaller experience in infants and small children. As in
many areas of medicine, the evolution from one form of
treatment to another is not based on controlled trials, and
the evidence base is largely from observational studies.
The study by Hamdan et al. (8) in this issue of the Journal
is the third report of stent implantation for aortic coarcta-
tion with a series of more than 30 patients (8–10). Two
smaller series of 17 patients each, an abstract of 15 patients
and a few single-figure studies and case reports make up the
current literature (11–14). Hamdan et al. (8) present en-
couraging short- and intermediate-term results in 33 chil-
dren and adults with a low morbidity and no mortality. In
one patient with a long segment recoarctation, stent im-
plantation was accomplished, but it was not possible to
dilate the stents to abolish the gradient, and surgical repair
was performed. Two other patients required surgery—one
for a retroperitoneal bleed and one to remove a fragment of
ruptured balloon. A clinically significant decline occurred in
the coarctation gradient, with a reduction in the systolic
blood pressure. Before the procedure 71% of the patients
were hypertensive; following stent implantation only 26%
remained hypertensive.
Technicalities of stent implantation. The technique of
stent implantation into the aorta has changed little since its
introduction in 1991 (15): a long, stiff guide wire is passed
across the lesion, followed by a long sheath through which
the stent balloon assembly is passed. After sheath with-
drawal the stent is deployed by inflating the balloon. The
study by Hamdan et al. (8) illustrates some of the difficulties
of stent placement. In three patients, stents were subopti-
mally positioned owing to migration of the partially ex-
panded stent in two patients or balloon rupture in one
patient and then fully dilated in an innocuous position. A
good outcome was obtained in two of these patients by
implantation of a second optimally positioned stent. All but
one of the stents used in the study were P308 or P188
Palmaz stents (Johnson & Johnson Interventional Systems,
Warren, New Jersey) with a theoretical maximum diameter
of 18 mm, and they have been the most commonly used
stents in congenital heart disease (15). Larger maximum
diameter Palmaz stents of at least 25 mm (P4014 and
P5014) are now available and may be more appropriate for
some adult aortas (11,12).
These longer stents (4 and 5 cm) also shorten less at the
diameters needed, thus improving the accuracy of stent
deployment and reducing the need for overlapping stents in
long segment obstructions. The outstanding advantage of
these stents is the radial strength, which prevents elastic
recoil, but the stent itself does not conform well to curved
vessels as might be necessary when approaching the isthmus
and proximal transverse aortic arch. The edges of these
stents are sharp and can cause the balloon to rupture (five in
the Hamdan et al. [8] series). Newer stent designs, includ-
ing platinum stents that are magnetic resonance imaging-
compatible and stents with rounded ends, are becoming
available (8). During balloon expansion of the stent, infla-
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tion pressures are usually kept below the rated burst pressure
of the selected balloon catheter. High pressures may be
needed for dilation in recoarctation, and Hamdan et al. (8)
used a pressure of 25 atm in one patient without successfully
overcoming the stenosis. The burst pressure of the aorta in
these circumstances is unknown, and high pressures should
be used cautiously. An inflation pressure of 12 atm during
stent implantation in a patient with recoarctation resistant
to balloon dilation has been accompanied by acute rupture
and near exsanguination (O’Sullivan J., personal communi-
cation, 2001). Rapid re-inflation of the balloon controlled
the situation, and emergency surgery was needed. “Test
dilation” of the coarctation before stent implantation is used
by some to confirm lesion compliance, though this inflation
may also cause vessel wall damage (10,11).
Graded or immediate full dilation of the stent. Hamdan
et al. (8) used an initial balloon of twice the coarctation
diameter and then additional balloons to a diameter not
exceeding the diameter of the isthmus or descending aorta
at the diaphragm. This strategy allowed the use of a slightly
smaller sheath for the initial stent balloon assembly to be
followed by larger balloons through the same sheath. Larger
balloons were also used to flare the distal end of the stent in
the poststenotic dilated aorta to promote complete endo-
thelialization of the stent. While flaring makes the angio-
graphic picture aesthetically more pleasing, it is not clear
whether this is necessary. Where there is significant post-
stenotic dilation, it is possible that flaring may result in the
sharp edges of the stent being forced into the distal aortic
wall at an angle to the lumen. No acute aneurysm formation
or dissection was seen, however, so full dilation of the
coarctation stent at the first procedure and flaring of the
stent ends proved an effective strategy in this series. Al-
though in the majority of reports the investigators have
aimed to dilate the stent to the perceived appropriate
diameter immediately, some have advocated deliberate un-
derdilation of the coarctation segment with later elective
redilation after endothelial lining of the stent has occurred
and medial tears have healed (11,13). This recommendation
evolved after aneurysms were observed when dilating the
stent to its full diameter acutely. Given the results in this
series, it may be reasonable to undertake full expansion of
the stent in patients with milder forms of coarctation (where
there is an increased risk of stent migration if the stent is not
fully expanded) and employ a graded dilation strategy in
those with severe coarctation.
Aneurysm formation. The incidence of aneurysm forma-
tion after balloon dilation and after surgery varies in the
literature according to the methodology used for its detec-
tion (6). A single randomized study revealed a higher
incidence after balloon dilation (5). Whereas an excessive
balloon size is commonly thought to be the culprit, other
technical factors (balloon rupture, catheter recrossing of the
dilated area) and the nature of the aortic wall may also be
responsible. Stent implantation, by avoiding the use of
excessively large balloons, and by abolishing the natural
elastic recoil of the coarctation segment, should be able to
treat the coarctation effectively without aneurysm forma-
tion. Hamdan et al. (8) did not detect any aneurysms but
only recatheterized four of their patients, and in two the
stents were further dilated so late angiography after the final
intervention was only obtained in two patients. Marshall et
al. (10) recatheterized 16 of 33 patients who had milder
degrees of recoarctation before stent implantation, but
redilated the stents in eight patients so angiography after the
last intervention was only obtained in eight patients—none
of whom had aneurysms.
In addition, Suarez de Lezo et al. (9) recatheterized 30 of
48 patients at a mean of 25 months and detected two new
aneurysms—an incidence of 7%. To avoid repeat angiogra-
phy, contrast-enhanced spiral computerized axial tomogra-
phy has been used for follow-up imaging, but this exposes
the patient to additional radiation (11,13). Therefore, mag-
netic resonance imaging would be ideal, but there is a degree
of artefact produced by the stent, and it is unclear how
accurate it will be for detecting small aneurysms that might
dictate the need for closer surveillance (16). The true
incidence of aneurysms will only be known when angiogra-
phy or computerized tomography (or more advanced mag-
netic resonance imaging) is performed as a routine after the
final dilation. Imaging may need to be repeated over the
years. Management of these aneurysms if expanding may
require surgical resection of the stented coarctation/
aneurysm segment with an interposition graft. An alterna-
tive would be the deployment of a covered stent inside the
stented coarctation to exclude the aneurysm (17). Currently,
these stents require 20F sheaths and surgical access to the
iliac vessels to implant. In smaller aneurysms, it has been
possible to implant vascular occlusion coils between the
stent struts to promote thrombosis of the aneurysm (9).
Transverse aortic arch stenting. Recoarctation is more
commonly observed in patients with transverse arch hyp-
oplasia (18). In many of these patients, the repair at the
coarctation site itself is satisfactory, and the level of the
obstruction is in the transverse arch. The increasing use of
extended arch repair in neonates and infants with coarcta-
tion may reduce the incidence of this problem, but currently
there are many patients in whom the transverse arch is the
site of the obstruction (19).
Hamdan et al. (8) implanted stents in three patients with
transverse arch hypoplasia and obtained good results with a
drop in the gradient. In one of these patients the stent
partially crossed the origin of the carotid artery. They
elected to use warfarin for six months to prevent cerebral
embolism from the stent. The rationale for this is not clear,
though intuitively there is concern when stenting is done
across such an important vessel. Portions of stent not
opposed to the vessel wall or crossing side branches do not
become endothelialized. Thus, if the stent struts were
postulated to be possible sources of emboli, then long-term
warfarin would be needed. Fortunately, in large vessels this
seems to be uncommon, and others have not reported
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problems (9,14). If positioning of the stent without dis-
placement is difficult in the descending aorta, then it is even
more difficult in the transverse arch. The use of shorter
stents, delivered with the balloon in balloon catheter (BIB,
NuMed, Nicholville, New York) may improve the ability to
stent the transverse arch accurately and safely without
compromising the arch vessels. A marker catheter in the left
carotid artery passed via a right brachial or transeptal
approach is also helpful (20). Though there would be less
concern about stenting across the origin of the subclavian
artery, it also seems sensible to avoid this if possible.
Threshold for stent implantation. Hamdan et al. (8)
included patients with coarctation or recoarctation based on
conventional criteria including an upper to lower limb blood
pressure gradient of 20 mm Hg and/or evidence of
coarctation on imaging. Lower gradients are generally
considered to be satisfactory end points for treatment and
nonintervention. This threshold for intervention has
evolved in response to the perceived risk-benefit ratio of
surgery for lower gradients and the difficulty of improving
lower gradients by balloon dilation due to inability to
overcome the elastic recoil of the milder lesions or the need
to use excessively large balloons with the attendant risk of
aneurysm formation. Patients with “mild coarctation,” how-
ever, may have raised upper body segment blood pressures
and may need long-term antihypertensive treatment or face
the consequences of a sustained, albeit mild, elevation in
blood pressure. Additionally, during exercise the blood
pressure response will be more pronounced (21,22). The
success of the technique in more severe coarctations may
therefore lead to a lowering of the threshold for intervention
(10). The definition of successful treatment of aortic coarc-
tation by any means may need to be revised in the light of
what is currently achievable with stent implantation.
Infants and small children. The smallest child in the
series by Hamdan et al. (8) was four years and weighed
18 kg. The indications in this child and the other young
children were not given. In two patients the stents were
redilated after patient growth without difficulty. In the other
larger series, several small children, including two infants,
underwent stent implantation, with the majority having had
previous surgical and or balloon dilation interventions
(9,12). Stent implantation was also described in a neonate
who had the stent resected and an end-to-end anastomosis
performed seven months later (23). There are two major
concerns with stenting the aorta in infants and small
children. The sheath size required for stent implantation
exceeds that of balloon catheters, and femoral artery occlu-
sions have been reported (9). For this reason carotid artery
access has been used by some investigators (11). In these
children, the stent diameter would not be adequate for the
aorta’s diameter when the child became an adult, and
growth would unmask a stenotic segment. While the
Palmaz stent is further dilatable during growth—as has been
demonstrated in experimental coarctations (though aortic
rupture has also been described in one model)—the ultimate
diameter of the aorta in a particular child is unknown
(24,25). Thus, implantation of a P308 stent will only allow
for dilation to 18 mm, which might not be enough in some
adults. In view of these concerns, stent implantation in
infants or small children should only be performed in
exceptional circumstances.
Conclusions. The study by Hamdan et al. (8) adds to the
literature on the subject and confirms that the early and
intermediate-term results of stent implantation in aortic
coarctation are good. Questions remain regarding the tech-
nicalities of implantation (balloon size, stent length and
diameter, inflation pressure, underdilation with elective
redilation, edge flaring, etc.), the need for caution when
implanting stents close to the arch vessels in arch hypoplasia
and the indications for this procedure in patients with mild
coarctation. More importantly, there is little data on the
incidence of late aneurysm formation and its progression
and the effects (if any) of a rigid segment of aortic wall on
blood pressure control over the long term. In the absence of
randomized trials, an international registry collecting pro-
spective data on all catheter interventions for coarctation
may be able to address some of these issues.
Despite these uncertainties, there are still some situations
where primary stent implantation would seem to be superior
to balloon dilation in adults. In transverse arch hypoplasia
there is no localized obstruction suitable for balloon dila-
tion, and thus elastic recoil is invariable. Similarly, in mild
recoarctation, excessively large balloons would be required
to overcome the elastic recoil, and they are more likely to
cause extensive medial tears to be effective. In these situa-
tions, if treatment is indicated, then stent implantation
would be the preferred option. At present, in the absence of
randomized trials, it is premature to conclude that stent
implantation is superior to balloon dilation in moderate to
severe coarctation and recoarctation. Nevertheless, in view
of the favorable short- and intermediate-term results, stent
implantation is rapidly becoming the preferred treatment
for older children and adults in many units. Long-term
results are now awaited.
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